Clinical Trials Logo

Cesarean Delivery clinical trials

View clinical trials related to Cesarean Delivery.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03335436 Withdrawn - Pain Management Clinical Trials

Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether a perioperative course of gabapentin in parturients on buprenorphine maintenance would improve analgesia after elective cesarean delivery (CD).

NCT ID: NCT03026647 Withdrawn - Clinical trials for Cesarean Section; Complications, Wound, Hematoma

Suture Material for Closure of Hysterotomy

Start date: January 31, 2017
Phase: N/A
Study type: Observational

Retrospective chart review evaluating different suture types on surgical outcomes for cesarean delivery and vaginal birth after cesarean delivery outcomes when different sutures are used.

NCT ID: NCT01880112 Withdrawn - Infection Clinical Trials

Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery.

Start date: June 2011
Phase: Phase 4
Study type: Interventional

Patients undergoing Cesarean delivery (C-Section) with a body mass index of 30 or less will be given either 2 grams or 4 grams of an antibiotic before surgery. The antibiotic is intended to prevent infection from the surgery. It is unknown what the best dose for the usual medicine used for this purpose (an antibiotic medicine called cefazolin). Samples of the tissue just under the skin will be biopsied at the time the incision is made and at the time the cut is stitched or stapled closed. A sample of the muscle of the womb will be taken as the womb is stitched closed after the delivery. Blood tests will be done at the start and end of surgery to test the antibiotic level. A blood sample will be taken from the umbilical cord after the baby has been delivered and the umbilical cord has been cut. The umbilical cord blood sample will be tested for the antibiotic level. These tests will be used to find out if the usual dose of medicine is enough or if more medicine is needed to prevent infection in normal weight women undergoing c-sections.

NCT ID: NCT01303107 Withdrawn - Cesarean Delivery Clinical Trials

Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the mixture of enantiomers of bupivacaine (bupivacaine S75:R25) dos not represent inferiority efficacy and safety compare to the racemic mixture of enantiomers of bupivacaine (bupivacaine S50:R50).